TSE:6645Electronic
Omron’s SF2030 Plan Targets Data Growth In Automation And Healthcare
OMRON (TSE:6645) has released its SF2030 2nd Stage medium term plan, outlining a broad shift toward data driven operations.
The plan highlights increased focus on industrial automation, healthcare, and targeted growth in Europe.
This roadmap sets out multi year priorities for redirecting investment and reshaping the company’s business mix.
OMRON, trading at ¥4,532.0, enters this new phase after a mixed share price record, with a 13.4% return year to date and a 3.5% return over 1 year,...